Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bestbion dx distributes a broad portfolio of commercialized diagnostic tests—including rapid tests and advanced biomarker assays—for infection diagnostics, acute care monitoring (sepsis/heart failure/kidney injury), and general laboratory use in Germany and Austria. The company partners with innovative assay developers to bring new biomarkers to market but does not develop its own therapeutics or diagnostics. Clinical results are those of the products it distributes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on bestbion dx.